Concluded: 2021

NivobotulinumtoxinA, a neuromodulator, in the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Line

This placebo-controlled pivotal study evaluated the safety and efficacy of NivobotulinumtoxinA, a neuromodulator, for the treatment of glabellar lines, aka frown lines, with or without concurrent treatment of lateral canthal lines, aka crow’s feet, in participants with moderate to severe glabellar lines and lateral canthal lines.